IL5 and myalgic encephalomeyelitis/chronic fatigue syndrome: Clarithromycin and mitomycin C could play a role in this process due to their anti-inflammatory effect, by inhibiting the production of pro-inflammatory cytokines, such as IL-5 and GM-CFS [44,49,57].